In Response to: “Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?”

Bibliographische Detailangaben

Veröffentlicht in:	Journal of thoracic oncology 2022-02, Vol.17 (2), p.e12-e14
Hauptverfasser:	Thomas, Nicholas J., Myall, Nathaniel J., Sun, Fangdi, Patil, Tejas, Mushtaq, Rao, Yu, Chandler, Sinha, Sumi, Pollom, Erqi L., Nagpal, Seema, Camidge, D. Ross, Rusthoven, Chad G., Braunstein, Steve E., Wakelee, Heather A., McCoach, Caroline E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Brain Neoplasms - radiotherapy Carcinoma, Non-Small-Cell Lung - radiotherapy ErbB Receptors - genetics Humans Lung Neoplasms - radiotherapy Receptor Protein-Tyrosine Kinases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!